TransEnterix, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRXDW research report →
About the company
Asensus Surgical, Inc. is a medical technology firm dedicated to the innovation, development, and commercialization of robotic surgical systems aimed at enhancing minimally invasive procedures. The company’s global reach extends across the United States, Europe, the Middle East, Africa, and Asia.
- CEO
- Anthony Fernando
- Employees
- 207
- HQ
- US
Price Chart
- Market Cap
- $40.09M
- P/E
- -0.48
- P/S
- 4.67
- P/B
- 1.12
- EV/EBITDA
- -0.39
- Div Yield
- 0.00%
- Gross Margin
- -58.66%
- Op Margin
- -910.92%
- Net Margin
- -914.46%
- ROE
- -117.89%
- ROIC
- -159.64%
- Revenue
- $8.58M · 21.02%
- Net Income
- $-78,433,000 · -3.80%
- EPS
- $-0.31 · 3.13%
- Op Income
- $-78,130,000
- FCF YoY
- -6.60%
- 52W High
- $0.15
- 52W Low
- $0.15
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.41
- Avg Volume
- 0
Get TickerSpark's AI analysis on TRXDW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TRXDW coverage
Recent articles, reports, and earnings notes.
No research on TRXDW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRXDW report →Similar companies
Peers in the same neighborhood.